Remote Ischemic Precondition Prevents Radial Artery Endothelial Dysfunction Induced by Ischemia and Reperfusion Based on A Cyclooxygenase-2-Dependent Mechanism

Zhen-Bing Liu,Wen-Xia Yang,Xiang-Hua Fu,Lin-Feng Zhao,Jun-Ling Gao

2015-01-01

Abstract:Ischemic preconditioning (IPC) and remote ischemic precondition (RIPC) are resistance to ischemia-reperfusion (IR) injury. They have common protective mechanism. Cyclooxygenase (COX)-2 participate in the mechanism of IPC. So, the purpose of this study was to determine whether RIPC protects endothelial function of radial artery in human against IR and whether COX-2 involves in this effect. Endothelial IR injury was induced by arm ischemia (20 min) and reperfusion. Flow-mediated dilation (FMD) of the radial artery was measured before and after IR. RIPC (three 5-min cycles of ischemia of the contralateral arm) was applied immediately and 24 h before IR. All volunteers received the COX-2 inhibitor celecoxib (200 mg orally twice daily) for 5 days. On day 6, all subjects experienced the same studies as described. FMD was reduced by IR without administration of RIPC (P< 0.0001). RIPC prevent this impairment of FMD immediately (P= NS) and at 24 h (P= NS). Nevertheless, the COX-2 inhibiter abolished protective effect of RIPC at 24 h (P= NS), but not immediately (P= 0.001). After administration of the COX-2 inhibiter, post-IR FMD after RIPC performed immediately had significant increase than after RIPC performed at 24 h (P= 0.001) and without administration of RIPC (P= 0.003). The COX-2 inhibiter made post-IR FMD evidently decrease after RIPC performed at 24 h (P= 0.002). RIPC prevents radial artery endothelial dysfunction induced by IR. This protective effect of RIPC in the late phase is mediated by a COX-2-dependent mechanism.